Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition and uses thereof

Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition and uses thereof

US Patent 8299095 · Granted Oct 30, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Catecholamine prodrugs for use in the treatment of Parkinson's disease2025
Crystalline forms of a MAGL inhibitor2024
1-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined 2022
1-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined 2022
Phenyl-piperazine derivatives as serotonin reuptake inhibitors2020
Dosing regimens for fast onset of antidepressant effect2019
Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperaz2018
Dosing regimens for fast onset of antidepressant effect2018
Methods for the preparation of 1,3-benzodioxole heterocyclic compounds2018
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined 2018
1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined 2018
Dosing regimens for fast onset of antidepressant effect2017